100
Participants
Start Date
July 24, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Left Atrial Appendage Occlusion
Acute ischemic stroke is a major cause of morbidity and mortality in non-valvular Atrial Fibrillation (AF). Oral Anticoagulation (OAC) with Warfarin and Direct oral anticoagulants (DOACs) has been the mainstay to prevent systemic thromboembolism (STE) in this patient population. It is estimated that around 50% of patients who have AF with indication for OAC end up being not on OAC due to bleeding complications leaving them at high risk for developing STE. Left atrial appendage occlusion (LAAO) offers an option in such population.
RECRUITING
Kansas City Heart Rhythm Institute, Overland Park
Kansas City Heart Rhythm Research Foundation
OTHER